You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Pain Assessment Interview and Clinical Advisory System

    SBC: Inflexxion, Inc.            Topic: NIDA

    DESCRIPTION (provided by applicant): This Phase II application continues development of the Pain Assessment Interview Network - Clinical Advisory System (painCAS), a systematic and tested computer-administered assessment of chronic pain patients. Initial Assessment and Follow-up modules assess relevant health and functioning information of patients as they enter or continue treatment for chronic p ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  2. Staying Off Substances: A Tailored Early Recovery Program for Teens

    SBC: Inflexxion, Inc.            Topic: NIDA

    DESCRIPTION (provided by applicant): The majority of adolescents struggling to avoid substance use during early recovery are also coping with many other issues (e.g., peer relationships) for which they require consistent support. We propose to develop an online relapse prevention program for adolescents called Staying Off Substances (SOS). Specific content in the program will be recommended to cou ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  3. Novel Glycosylated Delta Opioid Receptor Agonists for Chronic Inflammatory Pain

    SBC: BIOUSIAN BIOSYSTEMS, INC. (BBI)            Topic: NIDA

    DESCRIPTION (provided by applicant): Traditionally, Mu opioid receptor (MOR) agonists have not been given as first line treatments for neuropathic pain due to their significant adverse side effects. Biousian Biosystems Inc, (BBI) is developing novel glycosylated peptide-based delta opioid receptor (DOR) targeted drugs for the treatment of chronic pain. Preclinical profiles for DOR agonists indicat ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  4. MyStudentBody-Community College: A Health Website for Students

    SBC: Inflexxion, Inc.            Topic: NIDA

    DESCRIPTION (provided by applicant): In the current economic climate, community colleges are playing a more vital role than ever in educating the workforce. Enrollment at community colleges has grown by 17 percent since fall 2007 to a total enrollment of 8million (AACC, 2010a). Moreover, President Obama has called on community colleges to produce five million more graduates by 2020 (Gonzalez, 2010 ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  5. SOFTWARE FOR AUDITORY PROSTHESIS RESEARCH

    SBC: SENSIMETRICS CORP            Topic: NIDCD

    DESCRIPTION (provided by applicant): This project is for the development of software with research and clinical applications in the hearing sciences. In the research area, the software will allow investigators to work at a higher level of abstraction,providing monitoring and control applications for the design of complex sound processing strategies for hearing devices. The clinical application ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  6. New Communication Technology for Suddenly Speechless Hospitalized Patients

    SBC: CHAMELEON ADAPTIVEWARE, LLC            Topic: NIDCD

    DESCRIPTION (provided by applicant): Hospitalized patients faced with sudden inability to speak (e.g., patients with tracheal intubation) are unable to verbalize even the most basic comfort and care needs, or their urgent safety needs. These patients and nursing staff must consequently resort to alternative nonverbal communication strategies such as gestures, mouthing words, or the use of alphabet ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  7. An Implantable Pacemaker Optimized for Smooth Muscle Stimulation

    SBC: VIRGINIA TECHNOLOGIES, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Constipation is a common symptom affecting between 2 percent and 27 percent of the population in Western countries. In the United States, it results in more than 2.5 million visits to physicians, 92,000 hospitalizations, and laxative sales of several hundred million dollars a year. The use of a device to electrically stimulate smooth muscle proves particularly ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Ultrasound-triggered delivery of siRNA as treatment for diabetic kidney disease

    SBC: TARGESON, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Gene therapy in the context of diabetic kidney disease holds tremendous promise, although concrete progress in the field has been difficult to achieve. Specifically, the growth factor TGF-2 is known to play a critical role in glomerular matrix expansion and progression of glomerular fibrosis, and inhibition of TGF-2 activity by neutralizing antibodies has shown ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  9. IgA Protease as Therapy to Reverse IgA Nephropathy

    SBC: IGAN BIOSCIENCES, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Immunoglobulin A (IgA) nephropathy (IgAN) is one of the most common glomerulopathies worldwide, leading to kidney failure in up to 40% of those affected. This illness is caused by inflammation of the kidney brought about by extensive IgA1 protein deposits in all the renal glomeruli. It is considered likely that any therapy that can safely remove this IgA1 prote ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Development of a Fiberless Transflectance Noninvasive Glucose Monitor

    SBC: GROVE INSTRUMENTS, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Diabetes is a public health problem of epidemic proportions. It adversely affects morbidity, mortality, and overall healthcare costs. It is well known that frequent self-monitoring of blood glucose (SMBG) and good glycemic control can improve both cost and outcome. SMBG is not adequately embraced because current technology is painful, requires blood, and can be ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government